OS Therapies Incorporated
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +27,185.7% | -99.9% | +424.2% | -34.1% | +12,960.6% | |
| – | – | – | – | – | – | |
| – | +361,191.3% | +51.4% | -2.3% | -11.8% | +576,737.4% | |
| – | +188,923.9% | -23.3% | -2.9% | +254.7% | +310,482.2% | |
| – | +263,157.9% | +20.9% | -2.3% | +56.8% | +316.1% | |
| – | – | – | – | – | – | |
| – | -99.4% | -30.0% | +90.7% | -40.5% | -100.0% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | -7,983.2% | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.